Big Pharma Layoffs Continue: UNH, Merck, BMS, Novartis File WARN Notices for 2026 Cuts

Big Pharma companies such as Merck, Bristol Myers Squibb, Novartis, and UnitedHealth Group's Optum units are planning layoffs extending into 2026. The cuts are part of restructuring and cost-saving programs amid pressures from patent cliffs, pipeline reshuffling, operational overhauls, and profitability targets. UnitedHealth aims to restore profitability by 2027 through exiting unprofitable products, repricing coverage, and consolidating Optum systems. Merck is reducing 6,000 positions, or 8% of its workforce, while Bristol Myers Squibb is cutting 1,000 jobs statewide.